SCHEMBL8559800

SCHEMBL8559800

COc1ccccc1-c1oc(Cc2ccccc2)nc1NS(=O)(=O)c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC40A1 Q9NP59 2/20 0.45
MAPT P10636 3/20 0.44
ALDH1A1 P00352 2/20 0.44
RXRA P19793 1/20 0.42
CCNT1 O60563 1/20 0.42
CDK9 P50750 1/20 0.42
POLB P06746 1/20 0.41
KAT7 O95251 1/20 0.41
KAT6B Q8WYB5 1/20 0.41
KAT6A Q92794 1/20 0.41
KAT5 Q92993 1/20 0.41
KAT8 Q9H7Z6 1/20 0.41
CCR4 P51679 1/20 0.41
MCOLN2 Q8IZK6 1/20 0.40
MCOLN3 Q8TDD5 1/20 0.40
MCOLN1 Q9GZU1 1/20 0.40
GGT1 P19440 1/20 0.40
TSHR P16473 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
EDNRA P25101 4/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8554227 0.90 CCNT1 (0.49) SLC40A1MAPTALDH1A1CCNT1CDK9
SCHEMBL8553427 0.90 PIK3CD (0.48) SLC40A1MAPTALDH1A1GGT1SMN1; SMN2
SCHEMBL8556335 0.89 MAPT (0.44) SLC40A1MAPTALDH1A1POLBKAT7
SCHEMBL8559037 0.89 MAPT (0.46) SLC40A1MAPTALDH1A1GGT1SMN1; SMN2
SCHEMBL8556141 0.88 KAT6A (0.46) SLC40A1MAPTALDH1A1CCNT1CDK9
SCHEMBL8555761 0.85 MAPT (0.46) SLC40A1MAPTALDH1A1RXRATSHR
SCHEMBL8559996 0.85 CCNT1 (0.41) SLC40A1MAPTALDH1A1CCNT1CDK9
SCHEMBL8555336 0.85 MAPT (0.44) SLC40A1MAPTALDH1A1CCNT1CDK9
SCHEMBL8553792 0.85 MAPT (0.40) SLC40A1MAPTALDH1A1POLBCCR4
SCHEMBL8559481 0.85 ALDH1A1 (0.40) SLC40A1MAPTALDH1A1POLBKAT7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5719163-A ARTHRITIS G.D. SEARLE & CO. (US) 1998-02-17 US disclosed